Literature DB >> 26017162

A Method to Evaluate Fetal Erythropoiesis from Postnatal Survival of Fetal RBCs.

Denison J Kuruvilla1, John A Widness, Demet Nalbant, Robert L Schmidt, Donald M Mock, Peter Veng-Pedersen.   

Abstract

Fetal RBCs are produced during a period of very rapid growth and stimulated erythropoiesis under hypoxic intrauterine conditions. Fetal RBC life span varies with gestational age (GA) and is shorter than that in healthy adults. Due to the special kinetic properties of life span-based survival of human RBCs, a mathematical model-based kinetic analysis of the survival of fetal RBCs shortly after birth provides a unique opportunity to "look backward in time" to evaluate fetal erythropoiesis. This work introduces a novel method that utilizes postnatal in vivo RBC survival data collected within 2 days after birth to study both nonsteady-state (non-SS) in utero RBC production and changing fetal RBC life span over time. The effect of changes in erythropoiesis rate and RBC life span and the effect of multiple postnatal phlebotomies on the RBC survival curves were investigated using model-based simulations. This mathematical model, which considers both changes in the rate of erythropoiesis and RBC life span and which accurately accounts for the confounding effect of multiple phlebotomies, was applied to survival curves for biotin-labeled RBCs from ten anemic very low birth weight preterm infants. The estimated mean fetal RBC production rate scaled by body weight was 1.07 × 10(7) RBCs/day g, and the mean RBC life span at birth was 52.1 days; these values are consistent with reported values. The in utero RBC life span increased at a rate of 0.51 days per day of gestation. We conclude that the proposed mathematical model and its implementation provide a flexible framework to study in utero non-SS fetal erythropoiesis in newborn infants.

Entities:  

Mesh:

Year:  2015        PMID: 26017162      PMCID: PMC4540737          DOI: 10.1208/s12248-015-9784-y

Source DB:  PubMed          Journal:  AAPS J        ISSN: 1550-7416            Impact factor:   4.009


  26 in total

1.  Basic pharmacodynamic models for agents that alter production of natural cells.

Authors:  W Krzyzanski; R Ramakrishnan; W J Jusko
Journal:  J Pharmacokinet Biopharm       Date:  1999-10

2.  Red blood cell life span in the ovine fetus.

Authors:  R A Brace; C Langendörfer; T B Song; D M Mock
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2000-10       Impact factor: 3.619

Review 3.  Anemia in infancy.

Authors:  Jennifer Cobelli Kett
Journal:  Pediatr Rev       Date:  2012-04

Review 4.  Regulation of erythropoiesis in the fetus and newborn.

Authors:  P H Finne; S Halvorsen
Journal:  Arch Dis Child       Date:  1972-10       Impact factor: 3.791

5.  Specific gravity of blood and plasma at 4 and 37 degrees C.

Authors:  R J Trudnowski; R C Rico
Journal:  Clin Chem       Date:  1974-05       Impact factor: 8.327

6.  Studies on erythro-kinetics in infancy. 13. The mean life span and the life span frequency function of red blood cells formed during foetal life.

Authors:  L E Bratteby; L Garby; T Groth; W Schneider; B Wadman
Journal:  Acta Paediatr Scand       Date:  1968-07

Review 7.  Life-span of the fetal red blood cell.

Authors:  H A Pearson
Journal:  J Pediatr       Date:  1967-02       Impact factor: 4.406

8.  Mean remaining life span: a new clinically relevant parameter to assess the quality of transfused red blood cells.

Authors:  Denison J Kuruvilla; Demet Nalbant; John A Widness; Peter Veng-Pedersen
Journal:  Transfusion       Date:  2014-02-24       Impact factor: 3.157

9.  Posttransfusion red blood cell (RBC) survival determined using biotin-labeled RBCs has distinct advantages over labeling with (51) Cr.

Authors:  Donald M Mock; John A Widness; Ronald G Strauss; Robert S Franco
Journal:  Transfusion       Date:  2012-07       Impact factor: 3.157

10.  Population pharmacodynamic analysis of erythropoiesis in preterm infants for determining the anemia treatment potential of erythropoietin.

Authors:  Mohammad I Saleh; Demet Nalbant; John A Widness; Peter Veng-Pedersen
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2013-03-13       Impact factor: 3.619

View more
  5 in total

Review 1.  Development, validation, and potential applications of biotinylated red blood cells for posttransfusion kinetics and other physiological studies: evidenced-based analysis and recommendations.

Authors:  Donald M Mock; Demet Nalbant; Svetlana V Kyosseva; Robert L Schmidt; Guohua An; Nell I Matthews; Alexander P J Vlaar; Robin van Bruggen; Dirk de Korte; Ronald G Strauss; José A Cancelas; Robert S Franco; Peter Veng-Pedersen; John A Widness
Journal:  Transfusion       Date:  2018-05-16       Impact factor: 3.157

2.  A Mass Balance-Based Semiparametric Approach to Evaluate Neonatal Erythropoiesis.

Authors:  Denison J Kuruvilla; John A Widness; Demet Nalbant; Robert L Schmidt; Donald M Mock; Peter Veng-Pedersen
Journal:  AAPS J       Date:  2015-10-26       Impact factor: 4.009

3.  A Novel Physiology-Based Mathematical Model to Estimate Red Blood Cell Lifespan in Different Human Age Groups.

Authors:  Guohua An; John A Widness; Donald M Mock; Peter Veng-Pedersen
Journal:  AAPS J       Date:  2016-05-23       Impact factor: 4.009

4.  Altered erythropoiesis in newborns with congenital heart disease.

Authors:  Stephanie Y Tseng; Zhiqian Gao; Theodosia A Kalfa; Nicholas J Ollberding; Sammy Tabbah; Regina Keller; James F Cnota
Journal:  Pediatr Res       Date:  2021-02-02       Impact factor: 3.756

5.  Estimation of adult and neonatal RBC lifespans in anemic neonates using RBCs labeled at several discrete biotin densities.

Authors:  Denison J Kuruvilla; John A Widness; Demet Nalbant; Robert L Schmidt; Donald M Mock; Guohua An; Peter Veng-Pedersen
Journal:  Pediatr Res       Date:  2017-01-18       Impact factor: 3.756

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.